Latest Breaking News On - Chief executive ugur sahin - Page 7 : comparemela.com

Vaccines for kids under 12 will be submitted for approval within weeks

Vaccines for kids under 12 will be submitted for approval within weeks
thehill.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehill.com Daily Mail and Mail on Sunday newspapers.

United statesOezlem tuereciUgur sahinUs centers for diseaseDrug administrationMedical officer oezlem tuereciDer spiegelChief executive ugur sahinDisease control

BioNTech to seek global approval to use its COVID-19 vaccine in 5-11 year olds: report

BioNTech to seek global approval to use its COVID-19 vaccine in 5-11 year olds: report
cbc.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cbc.ca Daily Mail and Mail on Sunday newspapers.

Janet woodcockOezlem tuereciUgur sahinDrug administrationHealth canadaMedical officer oezlem tuereciChief executive ugur sahinCommissioner janet woodcockBiologics evaluation

BioNTech eyes building malaria, TB vaccine production sites in Rwanda, Senegal

New Delhi: COVID-19 vaccine maker BioNTech said on Friday it was looking into building malaria and tuberculosis vaccine production sites in Rwanda and Senegal, narrowing its search for African.

World health organizationAl qahirahSouth africaSouth africanAspen pharmacareInstitut pasteurMacky sallPaul kagameUgur sahinEuropean union commissionAfrica biovac institutePresident paul kagameSenegalese president macky sallEuropean union commission president ursulaChief executive ugur sahinBiovac institute

BioNTech Shuns Nigeria, eyes Rwanda, Senegal for malaria, tuberculosis

BioNTech in bid to build manufacturing expertise in Africa Project seeks to avoid repeat of COVID-19 vaccine inequality Biovaccines plans to raise about $30 million for vaccine plant in Nigeria Nigeria seeks to overcome dependence on imported vaccines Backed by EU Commission Aug 27 - with Nigeria in exclusion, COVID-19

South africaCape townWestern capeSouth sudanWorld health organizationAl qahirahSouth africanAspen pharmacareInstitut pasteurJohn nkengasongMacky sallPaul kagameUgur sahinBaker nigeria plcEu commissionWorld trade organization

BioNTech eyes Rwanda, Senegal for malaria, tuberculosis vaccine production

COVID-19 vaccine maker BioNTech (22UAy.DE) said on Friday it was looking into building malaria and tuberculosis vaccine production sites in Rwanda and Senegal, narrowing its search for African locations.

Thomas escrittLudwig burgerMacky sallPaul kagameUgur sahinThomson reuters trust principlesEuropean union commissionPresident paul kagameSenegalese president macky sallEuropean union commission president ursulaChief executive ugur sahinThomson reuters trust